- Product Theaters will take place at the Henry B. Gonzalez Convention Center
Loading view.
Product Theaters
Beyond the Chemotherapy Question: The New Era of Gene Expression Profiling with MammaPrint® + BluePrint®
Product Theater A
Presented by Agendia
Product Theaters
AstraZeneca Product Theater
Product Theater B
Presented by AstraZeneca
Product Theaters
Delve into TRODELVY (Sacituzumab govitecan-hziy) in Pretreated HR+/HER2-mBC
Product Theater A
Presented by Gilead Sciences, Inc.
Product Theaters
Discover an option for certain patients with ESR1-mutated mBC
Product Theater B
Presented by Menarini Stemline
Product Theaters
Explore the current data that could help you recognize/assess candidates for a CDK4 & 6 inhibitor
Product Theater A
Presented by Lilly
Featured Product Theaters
Come see clinical data for ENHERTU® (fam-trastuzumab deruxtecan-nxki)
Product Theater A
Presented by Daiichi Sankyo, Inc. and AstraZeneca
Product Theaters
MRD and Monitoring in Breast Cancer: a RaDaR Review and Discussion
Product Theater B
Presented by NeoGenomics Laboratories
Featured Product Theaters
Treatment Considerations for Specific Populations With HR+/HER2- Metastatic Breast Cancer
Product Theater A
Presented by Pfizer Oncology
Product Theaters
Integrating AI-Enabled Technology and Comprehensive Molecular Profiling to Enhance Breast Cancer Care
Product Theater B
Presented by Tempus
Product Theaters
Insights for treatment decision making with the Oncotype DX Breast Recurrence Score® test and the RSClin® Tool
Product Theater A
Presented by Exact Sciences
Product Theaters
Personalized ctDNA testing to help guide treatment decisions in breast cancer
Product Theater B
Presented by Natera, Inc.
Product Theaters
Brain Metastases in HER2+ Metastatic Breast Cancer: Current Clinical Insights
Product Theater A
Presented by Seagen
Product Theaters
Evolving Trends in HR+, Early-Stage Breast Cancer Diagnostics: Ovarian Function Suppression, Extended Endocrine Therapy and Beyond
Product Theater B
Presented by Biotheranostics